查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1930260

製藥生產設備市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察與預測（2026-2034）

Pharmaceutical Manufacturing Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 126 Pages | 商品交期: 請詢問到貨日

價格

製藥生產設備市場驅動因素

受藥品需求成長、技術快速進步和監管框架日益嚴格的推動，全球製藥生產設備市場持續穩定擴張。 2025年，該市場規模為236.7億美元。報告顯示，預計該市場將從2026年的251.4億美元成長至2034年的462.1億美元，在預測期（2026-2034年）內複合年增長率（CAGR）為7.9%。亞太地區在2025年引領全球市場，佔總市佔率的42.1%。

該市場競爭激烈，效率、合規性和技術創新在其中發揮著至關重要的作用。對生物製藥、精準醫療和高科技製造解決方案的投資增加，顯著提高了生產效率和合規性。此外，地緣政治趨勢、全球貿易動態以及不斷演變的環境、社會和治理 (ESG) 政策正在影響市場的長期擴張。

物聯網與自動化的影響

物聯網 (IoT) 和自動化技術的融合，透過提高品質控制、營運效率和法規遵從性，徹底改變了製藥生產。新冠疫情加速了數位轉型，推動了對快速、靈活的製造系統的需求，尤其是在疫苗和治療藥物方面。

支援物聯網的設備能夠實現即時監控、預測性維護和數據驅動的決策，而自動化則能減少對勞動力的依賴並最大限度地減少錯誤。這些進步正在推動對能夠快速響應治療藥物需求波動的自適應製造解決方案的投資。例如，2024 年 10 月，Korber 和 AspenTech 合作，將 PAS-X MES 與 AspenTech Information 整合。這為製藥廠商實現了無縫的現場整合和先進的資料管理。

製藥生產設備市場趨勢

影響市場趨勢最顯著的趨勢之一是連續生產的快速普及，這縮短了生產時間，提高了效率，並降低了營運成本。此外，一次性使用技術 (SUT) 因其能夠最大限度地降低污染風險並減少清潔和驗證要求而日益普及。

先進的防偽技術，包括滅菌系統和追溯解決方案，也變得越來越重要。製造商越來越關注專為滿足不斷變化的監管和營運要求的連續靈活生產環境而設計的設備。 2024年6月，GEA集團推出了首款用於灌注培養的一次性碟片離心機，支援高強度連續細胞分離。

市場動態

市場驅動因素：

市場成長主要受仿製藥、生物製品和活性藥物成分（API）需求不斷增長的驅動。 FDA和EMA等監管機構制定的監管要求對設備精度提出了更高的要求。外包給合約生產組織（CMO和CDMO）的增加以及工業4.0技術的日益普及進一步推動了市場成長。

市場限制因素：

巨額資本投資仍然是一個重大障礙，尤其對於中小型製造商而言。複雜的驗證流程、監管合規成本以及地緣政治不穩定導致的供應鏈中斷也阻礙了市場成長。

市場機會：

人們對永續和環保製造技術的興趣日益濃厚，這帶來了巨大的成長機會。節能減排設備的普及應用，以及向先進製造基礎設施有限的新興市場擴張，預計將支撐長期成長。

市場區隔分析

按設備類型劃分，乾燥機和造粒機市場佔有率最大，這主要歸功於其在先進配方製程中的關鍵作用。混合和攪拌設備預計將成長最快，到 2026 年將佔 22.79% 的市場。

按生產類型劃分，連續生產是成長最快的細分市場，預計複合年增長率將達到 8.27%。同時，預計到 2026 年，批量處理將佔主導地位，市場佔有率達到 58.23%。

按最終用戶劃分，CDMO（合約研發生產機構）細分市場佔主導地位，這主要得益於廣泛的外包和成本效益，預計其複合年增長率將達到 8.02%。

區域展望

預計亞太地區將引領市場，2025 年市場規模將達到 99.7 億美元，到 2026 年將成長至 107.1 億美元。預計中國市場規模將在 2026 年達到 43.6 億美元，其次是印度和日本，分別為 24.5 億美元和 14.5 億美元。

預計北美市場規模將在 2026 年達到 77.8 億美元，其次是歐洲，預計為 41.5 億美元。受醫療基礎設施不斷擴展的推動，中東和非洲地區預計到 2026 年市場規模將達到 14.2 億美元。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 宏觀與微觀經濟指標
  • 驅動因素、限制因素、機會與趨勢
  • 物聯網和自動化的影響

第四章：競爭格局

  • 主要公司採用的商業策略
  • 主要公司的綜合 SWOT 分析
  • 全球製藥生產設備市場前 3-5 大公司的市佔率/排名（2025 年）

章節5 全球製藥生產設備市場規模估算與預測（2021-2034）：依細分市場劃分

  • 主要發現
  • 依裝置劃分
    • 混合攪拌
    • 破碎
    • 乾燥機和製粒機
    • 擠出機
    • 灌裝和壓片
    • 檢定和滅菌
    • 包裝等
  • 依生產類型劃分
    • 連續式
    • 間歇式
  • 依最終用戶劃分
    • 大藥廠
    • CDMO
    • 合約生產
    • CRO
  • 按地區劃分
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東等地區非洲

第六章 北美製藥生產設備市場規模估算與預測（2021-2034）：依細分市場劃分

  • 依國家劃分
    • 美國
    • 加拿大
    • 墨西哥

第七章 南美製藥生產設備市場規模估算與預測（2021-2034）：依細分市場劃分

  • 依國家劃分
    • 巴西
    • 阿根廷
    • 其他南美國家

第八章 歐洲製藥生產設備市場規模估算與預測（2021-2034）：依細分市場劃分

  • 依國家/地區
    • 英國
    • 德國
    • 法國
    • 義大利
    • 瑞士
    • 西班牙
    • 其他歐洲國家

第九章：亞太地區製藥生產設備市場規模估算與預測（2021-2034）：依細分市場劃分

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 韓國
    • 東協
    • 其他亞太地區

第十章：中東與非洲製藥生產設備市場規模估算與預測（2021-2034）：依細分市場劃分

  • 依國家劃分
    • 南非洲
    • 海灣合作委員會 (GCC)
    • 中東和非洲其他地區

第11章 主要十大公司的企業簡介

  • GEA Group
  • Romaco Group
  • IMA Group
  • Syntegon Technology
  • Sartorius AG
  • ACG Group
  • Fette Compacting GmbH
  • Glatt
  • Paul Mueller Company
  • SED Pharma

第12章 主要點

Product Code: FBI112731

Growth Factors of pharmaceutical manufacturing equipment Market

The global pharmaceutical manufacturing equipment market is witnessing steady expansion driven by rising medicine demand, rapid technological advancements, and increasingly stringent regulatory frameworks. In 2025, the market was valued at USD 23.67 billion. According to the report, it is projected to grow from USD 25.14 billion in 2026 to USD 46.21 billion by 2034, registering a compound annual growth rate (CAGR) of 7.9% during the forecast period (2026-2034). The Asia Pacific region dominated the global market in 2025, accounting for 42.1% of the total share.

The market operates in a highly competitive environment where efficiency, regulatory compliance, and technological innovation play decisive roles. Rising investments in biopharmaceuticals, precision medicine, and high-tech manufacturing solutions are significantly improving production efficiency and compliance adherence. Additionally, geopolitical developments, global trade dynamics, and evolving Environmental, Social, and Governance (ESG) policies are influencing long-term market expansion.

Impact of IoT and Automation

The integration of Internet of Things (IoT) and automation technologies has transformed pharmaceutical manufacturing by improving quality control, operational efficiency, and regulatory compliance. The COVID-19 pandemic accelerated digital transformation, particularly increasing demand for high-speed and flexible manufacturing systems for vaccines and therapeutics.

IoT-enabled equipment supports real-time monitoring, predictive maintenance, and data-driven decision-making, while automation reduces labor dependency and minimizes errors. These advancements are driving investments in adaptable manufacturing solutions capable of responding swiftly to fluctuating therapeutic demand. For instance, in October 2024, Korber and AspenTech partnered to integrate PAS-X MES with AspenTech Inmation, enabling seamless shopfloor integration and advanced data management for pharmaceutical manufacturers.

Pharmaceutical Manufacturing Equipment Market Trends

One of the most prominent trends shaping the market is the rapid adoption of continuous manufacturing, which reduces production time, enhances efficiency, and lowers operational costs. Additionally, Single-Use Technologies (SUT) are gaining traction due to their ability to minimize contamination risks and reduce cleaning and validation requirements.

Advanced anti-counterfeiting technologies, including sterilization systems and track-and-trace solutions, are also gaining importance. Manufacturers are increasingly focusing on equipment designed for continuous and flexible manufacturing environments, aligning with evolving regulatory and operational requirements. In June 2024, GEA Group introduced the first single-use disc centrifuge for perfusion, supporting high-intensity continuous cell separation.

Market Dynamics

Market Drivers:

Growth is driven by rising demand for generic drugs, biologics, and Active Pharmaceutical Ingredients (API). Regulatory requirements set by authorities such as the FDA and EMA necessitate advanced precision equipment. Increased outsourcing to contract manufacturing organizations (CMOs and CDMOs) and growing adoption of Industry 4.0 technologies further support market expansion.

Market Restraints:

High capital investment remains a significant barrier, particularly for small and mid-sized manufacturers. Complex validation processes, regulatory compliance costs, and supply chain disruptions caused by geopolitical instability also pose challenges to market growth.

Market Opportunities:

The growing focus on sustainable and green manufacturing technologies presents major opportunities. Energy-efficient, waste-reducing equipment and expansion into emerging markets with limited advanced manufacturing infrastructure are expected to support long-term growth.

Segmentation Analysis

By equipment type, the dryer and granulator segment holds the largest market share due to its critical role in advanced formulation processes. Mixing and blending equipment is expected to witness the fastest growth, holding 22.79% market share in 2026.

By manufacturing type, continuous manufacturing is the fastest-growing segment, projected to grow at a CAGR of 8.27%, while batch processing is expected to dominate with 58.23% market share in 2026.

By end user, the CDMO segment leads the market, driven by extensive outsourcing and cost efficiency, and is expected to grow at a CAGR of 8.02%.

Regional Outlook

In 2025, Asia Pacific led the market with a value of USD 9.97 billion, increasing to USD 10.71 billion in 2026. China is expected to reach USD 4.36 billion in 2026, while India and Japan are projected at USD 2.45 billion and USD 1.45 billion, respectively.

North America is expected to reach USD 7.78 billion in 2026, followed by Europe at USD 4.15 billion. The Middle East & Africa is projected to reach USD 1.42 billion in 2026, supported by expanding healthcare infrastructure.

Conclusion

In conclusion, the pharmaceutical manufacturing equipment market is poised for sustained growth, expanding from USD 23.67 billion in 2025 to USD 46.21 billion by 2034. The convergence of automation, IoT, continuous manufacturing, and sustainable technologies is reshaping pharmaceutical production globally. Despite challenges such as high capital investment and regulatory complexities, strong demand for advanced medicines, API manufacturing, and outsourcing services ensures a positive long-term outlook for the market.

Segmentation By Equipment

  • Mixing & Blending
  • Milling
  • Dryer & Granulators
  • Extrusion
  • Filling & Compression
  • Inspection & Sterilization
  • Packaging, etc.

By Manufacturing Type

  • Continuous
  • Batch

By End User

  • Large Scale Pharma
  • CDMO
  • CMO
  • CRO

By Region

  • North America (By Equipment, By Manufacturing Type, By End User, and By Country)
    • U.S. (By End User)
    • Canada (By End User)
    • Mexico (By End User)
  • Europe (By Equipment, By End User, and By Country)
    • U.K. (By End User)
    • Germany (By End User)
    • France (By End User)
    • Italy (By End User)
    • Switzerland (By End User)
    • Spain (By End User)
    • Rest of Europe
  • Asia Pacific (By Equipment, By End User, and By Country)
    • China (By End User)
    • India (By End User)
    • Japan (By End User)
    • South Korea (By End User)
    • ASEAN (By End User)
    • Rest of Asia Pacific
  • Middle East & Africa (By Equipment, By End User, and By Country)
    • South Africa (By End User)
    • GCC (By End User)
    • Rest of Middle East & Africa
  • South America (By Equipment, By End User, and By Country)
    • Brazil (By End User)
    • Argentina (By End User)
    • Rest of South America

Key Market Players Profiled in the Report GEA Group AG (Germany), Syntegon Technology GmbH (Germany), Sartorius AG (Germany), ACG (India), IMA Group (Italy), Glatt GmbH (Germany), Romaco Group (Germany), Fette Compacting (Germany), Paul Mueller (U.S.), SED Pharma (China), etc.

Table of Content

1. Introduction

  • 1.1. Definition, By Segment
  • 1.2. Research Methodology/Approach
  • 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

  • 3.1. Macro and Micro Economic Indicators
  • 3.2. Drivers, Restraints, Opportunities and Trends
  • 3.3. Impact of IoT and Automation

4. Competition Landscape

  • 4.1. Business Strategies Adopted by Key Players
  • 4.2. Consolidated SWOT Analysis of Key Players
  • 4.3. Global Pharmaceutical Manufacturing Equipment Key Players [Top 3-5] Market Share/Ranking, 2025

5. Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 5.1. Key Findings
  • 5.2. By Equipment (USD)
    • 5.2.1. Mixing & Blending
    • 5.2.2. Milling
    • 5.2.3. Dryer & Granulators
    • 5.2.4. Extrusion
    • 5.2.5. Filling & Compression
    • 5.2.6. Inspection & Sterilization
    • 5.2.7. Packaging, etc.
  • 5.3. By Manufacturing Type (USD)
    • 5.3.1. Continuous
    • 5.3.2. Batch
  • 5.4. By End User (USD)
    • 5.4.1. Large Scale Pharmas
    • 5.4.2. CDMO
    • 5.4.3. CMO
    • 5.4.4. CRO
  • 5.5. By Region (USD)
    • 5.5.1. North America
    • 5.5.2. South America
    • 5.5.3. Europe
    • 5.5.4. Asia Pacific
    • 5.5.5. Middle East & Africa

6. North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 6.1. Key Findings
  • 6.2. By Equipment (USD)
    • 6.2.1. Mixing & Blending
    • 6.2.2. Milling
    • 6.2.3. Dryer & Granulators
    • 6.2.4. Extrusion
    • 6.2.5. Filling & Compression
    • 6.2.6. Inspection & Sterilization
    • 6.2.7. Packaging, etc.
  • 6.3. By Manufacturing Type (USD)
    • 6.3.1. Continuous
    • 6.3.2. Batch
  • 6.4. By End User (USD)
    • 6.4.1. Large Scale Pharmas
    • 6.4.2. CDMO
    • 6.4.3. CMO
    • 6.4.4. CRO
  • 6.5. By Country (USD)
    • 6.5.1. United States
      • 6.5.1.1. By End User
    • 6.5.2. Canada
      • 6.5.2.1. By End User
    • 6.5.3. Mexico
      • 6.5.3.1. By End User

7. South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 7.1. Key Findings
  • 7.2. By Equipment (USD)
    • 7.2.1. Mixing & Blending
    • 7.2.2. Milling
    • 7.2.3. Dryer & Granulators
    • 7.2.4. Extrusion
    • 7.2.5. Filling & Compression
    • 7.2.6. Inspection & Sterilization
    • 7.2.7. Packaging, etc.
  • 7.3. By Manufacturing Type (USD)
    • 7.3.1. Continuous
    • 7.3.2. Batch
  • 7.4. By End User (USD)
    • 7.4.1. Large Scale Pharmas
    • 7.4.2. CDMO
    • 7.4.3. CMO
    • 7.4.4. CRO
  • 7.5. By Country (USD)
    • 7.5.1. Brazil
      • 7.5.1.1. By End User
    • 7.5.2. Argentina
      • 7.5.2.1. By End User
    • 7.5.3. Rest of South America

8. Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 8.1. Key Findings
  • 8.2. By Equipment (USD)
    • 8.2.1. Mixing & Blending
    • 8.2.2. Milling
    • 8.2.3. Dryer & Granulators
    • 8.2.4. Extrusion
    • 8.2.5. Filling & Compression
    • 8.2.6. Inspection & Sterilization
    • 8.2.7. Packaging, etc.
  • 8.3. By Manufacturing Type (USD)
    • 8.3.1. Continuous
    • 8.3.2. Batch
  • 8.4. By End User (USD)
    • 8.4.1. Large Scale Pharmas
    • 8.4.2. CDMO
    • 8.4.3. CMO
    • 8.4.4. CRO
  • 8.5. By Country (USD)
    • 8.5.1. United Kingdom
      • 8.5.1.1. By End User
    • 8.5.2. Germany
      • 8.5.2.1. By End User
    • 8.5.3. France
      • 8.5.3.1. By End User
    • 8.5.4. Italy
      • 8.5.4.1. By End User
    • 8.5.5. Switzerland
      • 8.5.5.1. By End User
    • 8.5.6. Spain
      • 8.5.6.1. By End User
    • 8.5.7. Rest of Europe

9. Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 9.1. Key Findings
  • 9.2. By Equipment (USD)
    • 9.2.1. Mixing & Blending
    • 9.2.2. Milling
    • 9.2.3. Dryer & Granulators
    • 9.2.4. Extrusion
    • 9.2.5. Filling & Compression
    • 9.2.6. Inspection & Sterilization
    • 9.2.7. Packaging, etc.
  • 9.3. By Manufacturing Type (USD)
    • 9.3.1. Continuous
    • 9.3.2. Batch
  • 9.4. By End User (USD)
    • 9.4.1. Large Scale Pharmas
    • 9.4.2. CDMO
    • 9.4.3. CMO
    • 9.4.4. CRO
  • 9.5. By Country (USD)
    • 9.5.1. China
      • 9.5.1.1. By End User
    • 9.5.2. India
      • 9.5.2.1. By End User
    • 9.5.3. Japan
      • 9.5.3.1. By End User
    • 9.5.4. South Korea
      • 9.5.4.1. By End User
    • 9.5.5. ASEAN
      • 9.5.5.1. By End User
    • 9.5.6. Rest of Asia Pacific

10. Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 10.1. Key Findings
  • 10.2. By Equipment (USD)
    • 10.2.1. Mixing & Blending
    • 10.2.2. Milling
    • 10.2.3. Dryer & Granulators
    • 10.2.4. Extrusion
    • 10.2.5. Filling & Compression
    • 10.2.6. Inspection & Sterilization
    • 10.2.7. Packaging, etc.
  • 10.3. By Manufacturing Type (USD)
    • 10.3.1. Continuous
    • 10.3.2. Batch
  • 10.4. By End User (USD)
    • 10.4.1. Large Scale Pharmas
    • 10.4.2. CDMO
    • 10.4.3. CMO
    • 10.4.4. CRO
  • 10.5. By Country (USD)
    • 10.5.1. South Africa
      • 10.5.1.1. By End User
    • 10.5.2. GCC
      • 10.5.2.1. By End User
    • 10.5.3. Rest of MEA

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

  • 11.1. GEA Group
    • 11.1.1. Overview
      • 11.1.1.1. Key Management
      • 11.1.1.2. Headquarters
      • 11.1.1.3. Offerings/Business Segments
    • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.1.2.1. Employee Size
      • 11.1.2.2. Past and Current Revenue
      • 11.1.2.3. Geographical Share
      • 11.1.2.4. Business Segment Share
      • 11.1.2.5. Recent Developments
  • 11.2. Romaco Group
    • 11.2.1. Overview
      • 11.2.1.1. Key Management
      • 11.2.1.2. Headquarters
      • 11.2.1.3. Offerings/Business Segments
    • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.2.2.1. Employee Size
      • 11.2.2.2. Past and Current Revenue
      • 11.2.2.3. Geographical Share
      • 11.2.2.4. Business Segment Share
      • 11.2.2.5. Recent Developments
  • 11.3. IMA Group
    • 11.3.1. Overview
      • 11.3.1.1. Key Management
      • 11.3.1.2. Headquarters
      • 11.3.1.3. Offerings/Business Segments
    • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.3.2.1. Employee Size
      • 11.3.2.2. Past and Current Revenue
      • 11.3.2.3. Geographical Share
      • 11.3.2.4. Business Segment Share
      • 11.3.2.5. Recent Developments
  • 11.4. Syntegon Technology
    • 11.4.1. Overview
      • 11.4.1.1. Key Management
      • 11.4.1.2. Headquarters
      • 11.4.1.3. Offerings/Business Segments
    • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.4.2.1. Employee Size
      • 11.4.2.2. Past and Current Revenue
      • 11.4.2.3. Geographical Share
      • 11.4.2.4. Business Segment Share
      • 11.4.2.5. Recent Developments
  • 11.5. Sartorius AG
    • 11.5.1. Overview
      • 11.5.1.1. Key Management
      • 11.5.1.2. Headquarters
      • 11.5.1.3. Offerings/Business Segments
    • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.5.2.1. Employee Size
      • 11.5.2.2. Past and Current Revenue
      • 11.5.2.3. Geographical Share
      • 11.5.2.4. Business Segment Share
      • 11.5.2.5. Recent Developments
  • 11.6. ACG Group
    • 11.6.1. Overview
      • 11.6.1.1. Key Management
      • 11.6.1.2. Headquarters
      • 11.6.1.3. Offerings/Business Segments
    • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.6.2.1. Employee Size
      • 11.6.2.2. Past and Current Revenue
      • 11.6.2.3. Geographical Share
      • 11.6.2.4. Business Segment Share
      • 11.6.2.5. Recent Developments
  • 11.7. Fette Compacting GmbH
    • 11.7.1. Overview
      • 11.7.1.1. Key Management
      • 11.7.1.2. Headquarters
      • 11.7.1.3. Offerings/Business Segments
    • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.7.2.1. Employee Size
      • 11.7.2.2. Past and Current Revenue
      • 11.7.2.3. Geographical Share
      • 11.7.2.4. Business Segment Share
      • 11.7.2.5. Recent Developments
  • 11.8. Glatt
    • 11.8.1. Overview
      • 11.8.1.1. Key Management
      • 11.8.1.2. Headquarters
      • 11.8.1.3. Offerings/Business Segments
    • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.8.2.1. Employee Size
      • 11.8.2.2. Past and Current Revenue
      • 11.8.2.3. Geographical Share
      • 11.8.2.4. Business Segment Share
      • 11.8.2.5. Recent Developments
  • 11.9. Paul Mueller Company
    • 11.9.1. Overview
      • 11.9.1.1. Key Management
      • 11.9.1.2. Headquarters
      • 11.9.1.3. Offerings/Business Segments
    • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.9.2.1. Employee Size
      • 11.9.2.2. Past and Current Revenue
      • 11.9.2.3. Geographical Share
      • 11.9.2.4. Business Segment Share
      • 11.9.2.5. Recent Developments
  • 11.10. SED Pharma
    • 11.10.1. Overview
      • 11.10.1.1. Key Management
      • 11.10.1.2. Headquarters
      • 11.10.1.3. Offerings/Business Segments
    • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.10.2.1. Employee Size
      • 11.10.2.2. Past and Current Revenue
      • 11.10.2.3. Geographical Share
      • 11.10.2.4. Business Segment Share
      • 11.10.2.5. Recent Developments

12. Key Takeaways

List of Tables

  • Table 1: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 2: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 3: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 4: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 5: Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Region, 2021 - 2034
  • Table 6: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 7: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 8: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 9: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 10: North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 11: U.S. Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 12: Canada Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 13: Mexico Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 14: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 15: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 16: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 17: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 18: Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 19: U.K. Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 20: Germany Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 21: France Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 22: Italy Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 23: Switzerland Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 24: Spain Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 25: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 26: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 27: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 28: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 29: Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 30: China Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 31: India Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 32: Japan Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 33: South Korea Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 34: ASEAN Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 35: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 36: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 37: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 38: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 39: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 40: South Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 41: GCC Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 42: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, 2021 - 2034
  • Table 43: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Equipment, 2021 - 2034
  • Table 44: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Manufacturing Type, 2021 - 2034
  • Table 45: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 46: South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 47: Brazil Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 48: Argentina Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By End User, 2021 - 2034

List of Figures

  • Figure 1: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 2: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 3: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 4: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 5: Global Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Region, 2025 and 2034
  • Figure 6: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 7: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 8: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 9: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 10: North America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 11: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 12: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 13: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 14: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 15: Europe Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 16: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 17: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 18: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 19: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 20: Asia Pacific Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 21: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 22: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 23: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 24: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 25: Middle East & Africa Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 26: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), 2025 and 2034
  • Figure 27: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Equipment, 2025 and 2034
  • Figure 28: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Manufacturing Type, 2025 and 2034
  • Figure 29: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 30: South America Pharmaceutical Manufacturing Equipment Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 31: Global Pharmaceutical Manufacturing Equipment Market Key Players' Market Revenue Share(%), 2025